{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:21:52Z","timestamp":1783578112063,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Despite progress in conventional cancer therapies, cancer is still one of the leading causes of death in industrial nations. Therefore, an urgent need of progress in fighting cancer remains. A promising alternative to conventional methods is immune therapy. This relies on the fact that low-immunogenic tumours can be eradicated if an immune response against them is induced. Peptide vaccination is carried out by injecting tumour peptides into a patient to trigger a specific immune response against the tumour in its entirety. However, peptide vaccination is a highly complicated treatment and currently many factors like the optimal number of epitopes are not known precisely. Therefore, it is necessary to evaluate how certain parameters influence the therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We present the VaccImm Server that allows users to simulate peptide vaccination in cancer therapy. It uses an agent-based model that simulates peptide vaccination by explicitly modelling the involved cells (immune system and cancer) as well as molecules (antibodies, antigens and semiochemicals). As a new feature, our model uses real amino acid sequences to represent molecular binding sites of relevant immune cells. The model is used to generate detailed statistics of the population sizes and states of the single cell types over time. This makes the VaccImm web server well suited to examine the parameter space of peptide vaccination <jats:italic>in silico<\/jats:italic>. VaccImm is publicly available without registration on the web at <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/bioinformatics.charite.de\/vaccimm\" ext-link-type=\"uri\">http:\/\/bioinformatics.charite.de\/vaccimm<\/jats:ext-link>; all major browsers are supported.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The VaccImm Server provides a convenient way to analyze properties of peptide vaccination in cancer therapy. Using the server, we could gain interesting insights into peptide vaccination that reveal the complex and patient-specific nature of peptide vaccination.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2105-14-127","type":"journal-article","created":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T14:42:57Z","timestamp":1366036977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["VaccImm: simulating peptide vaccination in cancer therapy"],"prefix":"10.1186","volume":"14","author":[{"given":"Joachim","family":"von Eichborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Lena","family":"Woelke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Preissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,15]]},"reference":[{"key":"5868_CR1","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.4049\/jimmunol.0902539","volume":"186","author":"K Palucka","year":"2011","unstructured":"Palucka K, Ueno H, Banchereau J: Recent developments in cancer vaccines. J Immunol. 2011, 186: 1325-1331. 10.4049\/jimmunol.0902539.","journal-title":"J Immunol"},{"key":"5868_CR2","doi-asserted-by":"publisher","first-page":"e23257","DOI":"10.1371\/journal.pone.0023257","volume":"6","author":"AL Woelke","year":"2011","unstructured":"Woelke AL, Von Eichborn J, Murgueitio MS, Worth CL, Castiglione F, Preissner R: Development of immune-specific interaction potentials and their application in the multi-agent-system VaccImm. PLoS One. 2011, 6: e23257-10.1371\/journal.pone.0023257.","journal-title":"PLoS One"},{"key":"5868_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0378-4371(01)00201-1","volume":"297","author":"Y Louzoun","year":"2001","unstructured":"Louzoun Y, Solomon S, Atlan H, Cohen IR: Modeling complexity in biology. Physica A: Stat Mech and its Appl. 2001, 297: 242-252. 10.1016\/S0378-4371(01)00201-1.","journal-title":"Physica A: Stat Mech and its Appl"},{"key":"5868_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/0167-5699(92)90135-T","volume":"13","author":"F Celada","year":"1992","unstructured":"Celada F, Seiden PE: A computer model of cellular interactions in the immune system. Immunol Today. 1992, 13: 56-62. 10.1016\/0167-5699(92)90135-T.","journal-title":"Immunol Today"},{"key":"5868_CR5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.vaccine.2008.11.109","volume":"27","author":"Y Cheng","year":"2009","unstructured":"Cheng Y, Ghersi D, Calcagno C, Selin LK, Puzone R, Celada F: A discrete computer model of the immune system reveals competitive interactions between the humoral and cellular branch and between cross-reacting memory and na\u00efve responses. Vaccine. 2009, 27: 833-845. 10.1016\/j.vaccine.2008.11.109.","journal-title":"Vaccine"},{"key":"5868_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1742-4682-4-39","volume":"4","author":"VA Folcik","year":"2007","unstructured":"Folcik VA, An GC, Orosz CG: The Basic Immune Simulator: an agent-based model to study the interactions between innate and adaptive immunity. Theor Biol Med Model. 2007, 4: 39-10.1186\/1742-4682-4-39.","journal-title":"Theor Biol Med Model"},{"key":"5868_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtbi.2005.08.002","volume":"239","author":"DG Mallet","year":"2006","unstructured":"Mallet DG, De Pillis LG: A cellular automata model of tumor-immune system interactions. J Theor Biol. 2006, 239: 334-350. 10.1016\/j.jtbi.2005.08.002.","journal-title":"J Theor Biol"},{"key":"5868_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jtbi.2005.04.024","volume":"237","author":"F Castiglione","year":"2005","unstructured":"Castiglione F, Toschi F, Bernaschi M, Succi S, Benedetti R, Falini B, Liso A: Computational modeling of the immune response to tumor antigens. J Theor Biol. 2005, 237: 390-400. 10.1016\/j.jtbi.2005.04.024.","journal-title":"J Theor Biol"},{"key":"5868_CR9","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1093\/bioinformatics\/bti426","volume":"21","author":"F Pappalardo","year":"2005","unstructured":"Pappalardo F, Lollini P-L, Castiglione F, Motta S: Modeling and simulation of cancer immunoprevention vaccine. Bioinformatics. 2005, 21: 2891-2897. 10.1093\/bioinformatics\/bti426.","journal-title":"Bioinformatics"},{"key":"5868_CR10","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1093\/bioinformatics\/btr335","volume":"27","author":"N Rapin","year":"2011","unstructured":"Rapin N, Lund O, Castiglione F: Immune System Simulation Online. Bioinformatics. 2011, 27: 2013-2014. 10.1093\/bioinformatics\/btr335.","journal-title":"Bioinformatics"},{"key":"5868_CR11","doi-asserted-by":"publisher","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","volume":"5","author":"N Rapin","year":"2010","unstructured":"Rapin N, Lund O, Bernaschi M, Castiglione F: Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS One. 2010, 5: e9862-10.1371\/journal.pone.0009862.","journal-title":"PLoS One"},{"key":"5868_CR12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nbt1215","volume":"24","author":"M Moutaftsi","year":"2006","unstructured":"Moutaftsi M, Peters B, Pasquetto V, Tscharke DC, Sidney J, Bui H-H, Grey H, Sette A: A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol. 2006, 24: 817-819. 10.1038\/nbt1215.","journal-title":"Nat Biotechnol"},{"key":"5868_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/1471-2105-8-238","volume":"8","author":"M Nielsen","year":"2007","unstructured":"Nielsen M, Lundegaard C, Lund O: Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinforma. 2007, 8: 238-10.1186\/1471-2105-8-238.","journal-title":"BMC Bioinforma"},{"key":"5868_CR14","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1371\/journal.pbio.0030091","volume":"3","author":"B Peters","year":"2005","unstructured":"Peters B, Sidney J, Bourne P, Bui H-H, Buus S, Doh G, Fleri W, Kronenberg M, Kubo R, Lund O, Nemazee D, Ponomarenko JV, Sathiamurthy M, Schoenberger S, Stewart S, Surko P, Way S, Wilson S, Sette A: The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol. 2005, 3: e91-10.1371\/journal.pbio.0030091.","journal-title":"PLoS Biol"},{"key":"5868_CR15","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.1158\/1078-0432.CCR-04-2225","volume":"11","author":"J Jones","year":"2005","unstructured":"Jones J, Otu H, Spentzos D, Kolia S, Inan M, Beecken WD, Fellbaum C, Gu X, Joseph M, Pantuck AJ, Jonas D, Libermann TA: Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res. 2005, 11: 5730-5739. 10.1158\/1078-0432.CCR-04-2225.","journal-title":"Clin Cancer Res"},{"key":"5868_CR16","doi-asserted-by":"publisher","first-page":"D854","DOI":"10.1093\/nar\/gkp1004","volume":"38","author":"R Vita","year":"2010","unstructured":"Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R, Sette A, Peters B: The immune epitope database 2.0. Nucleic Acids Res. 2010, 38: D854-D862. 10.1093\/nar\/gkp1004.","journal-title":"Nucleic Acids Res"},{"key":"5868_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nrc841","volume":"2","author":"S Stevanovic","year":"2002","unstructured":"Stevanovic S: Identification of tumour-associated T-cell epitopes for vaccine development. Nat Rev Cancer. 2002, 2: 514-520. 10.1038\/nrc841.","journal-title":"Nat Rev Cancer"},{"key":"5868_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ijmm.2008.01.012","volume":"298","author":"G Nagy","year":"2008","unstructured":"Nagy G, Emody L, P\u00e1l T: Strategies for the development of vaccines conferring broad-spectrum protection. Int J Med Microbiol. 2008, 298: 379-395. 10.1016\/j.ijmm.2008.01.012.","journal-title":"Int J Med Microbiol"},{"key":"5868_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1006\/clin.1997.4449","volume":"86","author":"WM Ridgway","year":"1998","unstructured":"Ridgway WM, Fathman CG: The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes. Clin Immunol Immunopathol. 1998, 86: 3-10. 10.1006\/clin.1997.4449.","journal-title":"Clin Immunol Immunopathol"},{"issue":"Suppl","key":"5868_CR20","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1017\/S0031182000076654","volume":"112","author":"EM Riley","year":"1996","unstructured":"Riley EM: The role of MHC- and non-MHC-associated genes in determining the human immune response to malaria antigens. Parasitology. 1996, 112 (Suppl): S39-S51.","journal-title":"Parasitology"},{"key":"5868_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1365-2567.2010.03268.x","volume":"130","author":"M Nielsen","year":"2010","unstructured":"Nielsen M, Lund O, Buus S, Lundegaard C: MHC class II epitope predictive algorithms. Immunology. 2010, 130: 319-328. 10.1111\/j.1365-2567.2010.03268.x.","journal-title":"Immunology"},{"key":"5868_CR22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nm0597-505","volume":"3","author":"JW Uhr","year":"1997","unstructured":"Uhr JW, Scheuermann RH, Street NE, Vitetta ES: Cancer dormancy: opportunities for new therapeutic approaches. Nat Med. 1997, 3: 505-509. 10.1038\/nm0597-505.","journal-title":"Nat Med"},{"key":"5868_CR23","first-page":"863","volume":"23","author":"HJ Rayala","year":"2009","unstructured":"Rayala HJ, Richie JP: Radical prostatectomy reigns supreme. Oncology (Williston Park). 2009, 23: 863-867.","journal-title":"Oncology (Williston Park)"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-14-127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T23:52:31Z","timestamp":1630540351000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-14-127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,15]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["5868"],"URL":"https:\/\/doi.org\/10.1186\/1471-2105-14-127","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,15]]},"assertion":[{"value":"27 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"127"}}